MEDP — Medpace Holdings Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapHigh Flyer

Annual cashflow statement for Medpace Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	145	182	245	283	404
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items	27	30.8	37.3	42.9	44.6
Other Non-Cash Items
Changes in Working Capital	66.3	66.7	106	106	157
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Cash from Operating Activities	259	263	388	433	609
Capital Expenditures	-31.3	-28.3	-36.9	-36.6	-36.5
Purchase of Fixed Assets
Other Investing Cash Flow Items	0.126	-3.09	-1.86	2.02	8.24
Other Investing Cash Flow
Cash from Investing Activities	-31.2	-31.4	-38.7	-34.6	-28.3
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-82.3	-44.5	-776	-183	-154
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	146	184	-433	217	424